[The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors].

Tsubura, E

[The phase I and early phase II studies of human lymphoblast interferon (MOR-22) in the treatment of malignant tumors]. [electronic resource] - Nihon Gan Chiryo Gakkai shi Jun 1986 - 1049-58 p. digital

Publication Type: English Abstract; Journal Article

0021-4671


Adolescent
Adult
Aged
Carcinoma, Renal Cell--drug therapy
Drug Evaluation
Female
Head and Neck Neoplasms--drug therapy
Humans
Interferon Type I--adverse effects
Kidney Neoplasms--drug therapy
Leukemia, Myeloid, Acute--drug therapy
Male
Middle Aged